DAMAE Medical
4 known investors
Damae Medical develops deepLive, a non-invasive skin imaging system based on LC-OCT (Line-field Confocal Optical Coherence Tomography) that produces 3D histology-like and confocal-like images of skin tissue. The device is used by dermatologists to image and assess skin conditions including melanoma and carcinoma.
Deep TechDigital HealthMedical Devices
Founders & leadership
AB
Anaïs BarutCo-founder & CEO
DS
David SiretCo-founder & CTO
AD
Arnaud DuboisCo-founder & CSO
Investors · 4
Frequently asked questions
- What does DAMAE Medical do?
- Damae Medical develops deepLive, a non-invasive skin imaging system based on LC-OCT (Line-field Confocal Optical Coherence Tomography) that produces 3D histology-like and confocal-like images of skin tissue. The device is used by dermatologists to image and assess skin conditions including melanoma and carcinoma.
- Who are DAMAE Medical's investors?
- DAMAE Medical's investors include Paris-Saclay Seed Fund, Idinvest Partners, Kurma Partners, Partech Ventures.